Form 4: Scholar Rock Holding Corp: Chief Medical Officer Jing L. Marantz Executes Stock Option and Sells Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4


Jing L. Marantz, Chief Medical Officer of Scholar Rock Holding Corp, exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • On October 7, 2024, Jing L. Marantz, the Chief Medical Officer of Scholar Rock Holding Corp, executed a stock option to acquire 109,375 shares at a price of $8.59 per share.
  • Marantz also sold shares of common stock in multiple transactions at weighted average prices of $25.5885, $26.2236, and $30.061.
  • The sales involved 67,448 shares, 2,552 shares, and 39,375 shares respectively.
  • These transactions were conducted under a Rule 10b5-1 trading plan adopted on April 19, 2024.
  • Following these transactions, Marantz directly owns 72,855 shares of common stock.
  • Marantz also directly owns 140,625 stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral. While insider sales can sometimes be viewed negatively, the presence of a 10b5-1 plan suggests the transactions were pre-planned and not based on current, non-public information. The exercise of options is a positive sign.

Positives

  • The transactions were executed under a pre-existing Rule 10b5-1 trading plan, which can mitigate concerns about insider trading.

Negatives

  • The sale of shares by a high-ranking officer could be interpreted negatively by some investors, although the 10b5-1 plan provides context.

Risks

  • The market may react negatively to the sale of shares by a company insider, even if it's part of a pre-planned strategy.

Industry Context

Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders. The use of a 10b5-1 plan is a common practice to allow insiders to sell shares without raising concerns about trading on non-public information.

Stakeholder Impact

  • Shareholders may react to the news of insider selling, although the 10b5-1 plan provides context.

Key Dates

DateDescription
2023-11-0925% of stock options vested.
2024-04-19Date of adoption of Rule 10b5-1 trading plan.
2024-10-07Date of stock option exercise and stock sales.
2032-11-14Expiration date of stock options.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.